Unknown

Dataset Information

0

Structural Basis of Detection and Signaling of DNA Single-Strand Breaks by Human PARP-1.


ABSTRACT: Poly(ADP-ribose)polymerase 1 (PARP-1) is a key eukaryotic stress sensor that responds in seconds to DNA single-strand breaks (SSBs), the most frequent genomic damage. A burst of poly(ADP-ribose) synthesis initiates DNA damage response, whereas PARP-1 inhibition kills BRCA-deficient tumor cells selectively, providing the first anti-cancer therapy based on synthetic lethality. However, the mechanism underlying PARP-1's function remained obscure; inherent dynamics of SSBs and PARP-1's multi-domain architecture hindered structural studies. Here we reveal the structural basis of SSB detection and how multi-domain folding underlies the allosteric switch that determines PARP-1's signaling response. Two flexibly linked N-terminal zinc fingers recognize the extreme deformability of SSBs and drive co-operative, stepwise self-assembly of remaining PARP-1 domains to control the activity of the C-terminal catalytic domain. Automodification in cis explains the subsequent release of monomeric PARP-1 from DNA, allowing repair and replication to proceed. Our results provide a molecular framework for understanding PARP inhibitor action and, more generally, allosteric control of dynamic, multi-domain proteins.

SUBMITTER: Eustermann S 

PROVIDER: S-EPMC4678113 | biostudies-literature | 2015 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structural Basis of Detection and Signaling of DNA Single-Strand Breaks by Human PARP-1.

Eustermann Sebastian S   Wu Wing-Fung WF   Langelier Marie-France MF   Yang Ji-Chun JC   Easton Laura E LE   Riccio Amanda A AA   Pascal John M JM   Neuhaus David D  

Molecular cell 20151125 5


Poly(ADP-ribose)polymerase 1 (PARP-1) is a key eukaryotic stress sensor that responds in seconds to DNA single-strand breaks (SSBs), the most frequent genomic damage. A burst of poly(ADP-ribose) synthesis initiates DNA damage response, whereas PARP-1 inhibition kills BRCA-deficient tumor cells selectively, providing the first anti-cancer therapy based on synthetic lethality. However, the mechanism underlying PARP-1's function remained obscure; inherent dynamics of SSBs and PARP-1's multi-domain  ...[more]

Similar Datasets

| S-EPMC7347020 | biostudies-literature
| S-EPMC7038996 | biostudies-literature
| S-EPMC3094755 | biostudies-literature
| S-EPMC5133665 | biostudies-literature
| S-EPMC8604939 | biostudies-literature
| S-EPMC3102116 | biostudies-literature
| S-EPMC4359693 | biostudies-literature
| S-EPMC3224808 | biostudies-literature
| S-EPMC2584354 | biostudies-literature
| S-EPMC7544215 | biostudies-literature